JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, M. P. L.
Right arrow Articles by Chiu, W. K. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, M. P. L.
Right arrow Articles by Chiu, W. K. Y.
Related Collections
Right arrow Pharmacology
Right arrow Airway
Anesth Analg 2001;93:359-362
© 2001 International Anesthesia Research Society

ANESTHETIC PHARMACOLOGY

The Use of Remifentanil to Facilitate the Insertion of the Laryngeal Mask Airway

Monica P. L. Lee, FANZCA, Jeffrey S. W. Kua, FANZCA, FHKAM, and Wallace K. Y. Chiu, FRCA, FHKAM, FANZCA

Department of Anaesthesia and Intensive Care, Pamela Youde Nethersole Eastern Hospital, Hong Kong Special Administrative Region, China

Address correspondence to Dr. Monica P. L. Lee, Department of Anaesthesia and Intensive Care, Pamela Youde Nethersole Eastern Hospital, 3 Lok Man Road, Hong Kong Special Administrative Region, China. Reprints will not be available.

Propofol is often used as an IV induction drug for anesthesia and the insertion of a laryngeal mask airway (LMA). As a sole anesthetic, it may be associated with undesirable airway responses such as coughing and gagging. We conducted a randomized, double-blinded study to compare the conditions during insertion of the LMA in 120 patients who received normal saline (Group P), remifentanil 0.25 µg/kg (Group R1), or remifentanil 0.5 µg/kg (Group R2) before the induction of anesthesia with IV propofol. The addition of remifentanil significantly improved the conditions of insertion; in Group R1, 82.5% (33 of 40 patients), and in Group R2, 85.0% (34 of 40 patients) had excellent insertion conditions as compared with the Control group P, 32.5% (13 of 40 patients). Patients in Group P were apneic for a mean (SD) time of 85 (38) s, 186 (75) s in group R1, and 284 (130) s in group R2. There was a lesser decrease in mean arterial blood pressure in group R1. We conclude that remifentanil 0.25 µg/kg, when administered after IV propofol 2.5 mg/kg, provides excellent conditions for insertion of the LMA with minimal hemodynamic disturbances.

IMPLICATIONS: Small-dose remifentanil can provide excellent conditions for laryngeal mask airway insertion with minimal hemodynamic disturbances.




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
H.-J. Park, J.-R. Lee, C. S. Kim, S. D. Kim, and H.-S. Kim
Remifentanil Halves the EC50 of Propofol for Successful Insertion of the Laryngeal Mask Airway and Laryngeal Tube in Pediatric Patients
Anesth. Analg., July 1, 2007; 105(1): 57 - 61.
[Abstract] [Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2001 by the International Anesthesia Research Society.